The Family Firm’s Johnson & Johnson JNJ Stock Holding History

The Family Firm’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,439	Closed	-$570K	–	145
2025 Q1	$570K	Buy	3,439 +18	+0.5%	+$2.82K	0.13%	106
2024 Q4	$495K	Buy	3,421 +21	+0.6%	+$3.25K	0.11%	114
2024 Q3	$551K	Buy	3,400 +81	+2%	+$12.9K	0.12%	108
2024 Q2	$485K	Buy	3,319 +22	+0.7%	+$3.27K	0.11%	112
2024 Q1	$522K	Buy	3,297 +24	+0.7%	+$3.82K	0.13%	106
2023 Q4	$513K	Buy	3,273 +24	+0.7%	+$3.68K	0.13%	103
2023 Q3	$506K	Buy	3,249 +23	+0.7%	+$3.79K	0.14%	98
2023 Q2	$534K	Buy	3,226 +23	+0.7%	+$3.71K	0.14%	98
2023 Q1	$496K	Buy	3,203 +23	+0.7%	+$3.71K	0.14%	101
2022 Q4	$562K	Buy	3,180 +20	+0.6%	+$3.45K	0.16%	97
2022 Q3	$516K	Buy	3,160 +21	+0.7%	+$3.55K	0.17%	94
2022 Q2	$557K	Sell	3,139 -29	-0.9%	-$5.17K	0.16%	94
2022 Q1	$562K	Buy	3,168 +19	+0.6%	+$3.23K	0.15%	92
2021 Q4	$539K	Buy	3,149 +19	+0.6%	+$3.11K	0.14%	97
2021 Q3	$513K	Buy	3,130 +103	+3%	+$17.6K	0.13%	95
2021 Q2	$499K	Buy	3,027 +19	+0.6%	+$3.15K	0.14%	100
2021 Q1	$494K	Buy	3,008 +18	+0.6%	+$2.91K	0.14%	96
2020 Q4	$479K	Sell	2,990 -399	-12%	-$58.9K	0.14%	98
2020 Q3	$504K	Sell	3,389 -154	-4%	-$22.8K	0.18%	83
2020 Q2	$498K	Buy	3,543 +17	+0.5%	+$2.48K	0.19%	80
2020 Q1	$462K	Sell	3,526 -107	-3%	-$15.2K	0.2%	78
2019 Q4	$530K	Sell	3,633 -1,848	-34%	-$251K	0.18%	82
2019 Q3	$709K	Buy	5,481 +7	+0.1%	+$922	0.25%	64
2019 Q2	$762K	Buy	5,474 +5	+0.1%	+$692	0.27%	64
2019 Q1	$764K	Sell	5,469 -134	-2%	-$17.9K	0.28%	62
2018 Q4	$723K	Sell	5,603 -21	-0.4%	-$2.93K	0.29%	60
2018 Q3	$777K	Sell	5,624 -102	-2%	-$13.6K	0.28%	61
2018 Q2	$695K	Sell	5,726 -515	-8%	-$64.3K	0.26%	60
2018 Q1	$800K	Buy	6,241 +306	+5%	+$41.4K	0.31%	54
2017 Q4	$829K	Sell	5,935 -24	-0.4%	-$3.34K	0.33%	53
2017 Q3	$775K	Buy	5,959 +641	+12%	+$85K	0.32%	57
2017 Q2	$703K	Buy	5,318 +627	+13%	+$80K	0.31%	58
2017 Q1	$584K	Buy	4,691 +30	+0.6%	+$3.58K	0.28%	58
2016 Q4	$537K	Buy	4,661 +6	+0.1%	+$693	0.25%	61
2016 Q3	$550K	Buy	4,655 +206	+5%	+$25K	0.26%	61
2016 Q2	$540K	Buy	4,449 +20	+0.5%	+$2.27K	0.27%	57
2016 Q1	$479K	Buy	4,429 +6	+0.1%	+$621	0.24%	61
2015 Q4	$454K	Sell	4,423 -418	-9%	-$42K	0.24%	65
2015 Q3	$452K	Buy	4,841 +354	+8%	+$34.2K	0.25%	65
2015 Q2	$437K	Sell	4,487 -1,422	-24%	-$142K	0.22%	67
2015 Q1	$594K	Buy	5,909 +102	+2%	+$10.4K	0.3%	52
2014 Q4	$607K	Buy	+5,807	New	+$612K	0.32%	50

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

The Family Firm's JNJ Position: Q2 2025 in Review

The Family Firm sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 3,439 shares — an estimated $570K sold.

The Family Firm first reported a position in JNJ in Q4 2014 and held it in 42 quarters. The position peaked at $829K in Q4 2017. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

The Family Firm reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
The Family Firm sold 3,439 Johnson & Johnson shares in Q2 2025, an estimated $570K.
The Family Firm first reported a position in Johnson & Johnson in Q4 2014 and held it in 42 quarters.
The Family Firm's Johnson & Johnson position peaked at $829K in Q4 2017.
4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on The Family Firm's 13F filing for Q2 2025, filed 8 Aug 2025.